GLAXOSMITHKLINE INTERNATIONAL LIMITED
Company number 02298366 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- Private Limited Company
- Incorporated
- 1988-09-21
- Registered office
- 79 New Oxford Street, London, United Kingdom, WC1A 1DG
- Postcode
- WC1A 1DG
- Capital
- 10,000 GBP
- Accounts category
- Audit Exemption Subsidiary
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-08-24
- Next due by
- 2027-09-07
Nature of business (SIC)
- 82990 Other business support service activities not elsewhere classified
Officers 5 current · 22 resigned
Alistair Robert DAVIDSON
Director
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED
Secretary · corporate
GLAXO GROUP LIMITED
Corporate Director · corporate
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED
Director · corporate
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED
Corporate Director
Group structure
Controlled by SETFIRST LIMITED — since 2016-04-06
From persons-with-significant-control filings on the public register.
Contact details
- Website
- glaxosmithkline.org.uk
Previous company names
| Name | Date changed |
|---|---|
| SMITHKLINE BEECHAM INTERNATIONAL LIMITED | 2004-10-27 |
| SMITHKLINE BECKMAN INTERNATIONAL LIMITED | 1989-09-06 |
| MONOLANCE LIMITED | 1988-10-21 |
Previous registered addresses 4
| Address | Changed on |
|---|---|
| FOUR NEW HORIZONS COURT, HARLEQUIN AVENUE, BRENTFORD, MIDDLESEX TW8 9EP | 2002-02-06 |
| MUNDELLS, WELWYN GARDEN CITY, HERTFORDSHIRE, AL7 1EY | 1993-12-03 |
| ALTON HOUSE, 174-177 HIGH HOLBORN, LONDON, WC1V 7AA | 1989-11-30 |
| 2 BACHES STREET, LONDON, N1 6UB | 1988-11-04 |
Among its peers
Among the oldest 25%
of 4,575 similar companies in WC, trading since 1988
The class of 1988
36%
of the 724 companies in this sector incorporated in 1988 are still active today; 62% have since been dissolved.
A fact about the year, not a forecast for this company.